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Abstract 
Selective cleavage of the (2-naphthyl)methyl (NAP) group in the presence of p-methoxybenzyl 
(PMB), benzyl and benzylidene groups was achieved by catalytic hydrogenation with a series of 
monosaccharides. At a disaccharide level, the PMB group was stable upon hydrogenolysis of the 
NAP, however, partial cleavage of benzyl ether functions was observed. 
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Introduction 
 
In carbohydrate chemistry, the benzyl-type ethers are the most frequently used protecting groups, 
since they are removable upon mild catalytic hydrogenation, and, due to their different 
reactivities, adoptable in orthogonal protecting strategies.1 The p-methoxybenzyl (PMB) ether 
can be cleaved selectively by DDQ (2,3-dichloro-5,6-dicyano-1,4-benzoquinone)2 or CAN 
(cerium(IV) ammonium nitrate)3,4 leaving most of the protecting groups intact, therefore, it 
became one of the most popular tools for temporary hydroxyl protection. However, the PMB 
group has the disadvantage of extreme acid-sensitivity. The 2-(naphthyl)methyl (NAP) group,5,6 
being removable by either catalytic hydrogenation6-8 or DDQ9 in the presence of benzyl ether 
and, unlike its p-methoxybenzyl counterpart, being stable under acidic conditions, seems to be a 
remarkably useful protecting group for polyhydroxy systems.  
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Recently, Spencer et al. have demonstrated a sequential deprotection strategy for sugars 
based upon the PMB, NAP and benzyl groups, applying CAN as a selective reagent to cleave 
PMB in the presence of the NAP-ether.4 This set of benzyl-type protecting groups would be 
more useful, if orthogonal deprotection of NAP would be carried out  in the presence of PMB. 
Investigating the relative stability of benzyl, p-methoxybenzyl, 2-(naphthyl)methyl, 1-
(naphthyl)methyl,10,11 diphenylmethyl, 9-fluorenyl and p-chlorobenzyl ethers to catalytic 
hydrogenation in competitive reactions, we have found that splitting of the substituted benzyl 
ethers such as PMB did not start until the removal of the extended aromatic system became 
complete.12,13  
To explore the utility of this observation, a series of mono- and disaccharides carrying NAP 
and PMB groups were prepared and subjected to catalytic hydrogenation.  
 
 
Results and Discussion 
 
Fully protected glucoside derivatives 2 and 5 carrying benzyl, p-methoxybenzyl and 2-
(naphthyl)methyl protecting groups were prepared by conventional alkylation, starting from 114 
and 4,14 respectively. Tlc monitoring of the Pd/C-catalyzed hydrogenolysis of 2 showed 
formation of a single product until the conversion reached at 80-90%;  prolongation of the 
reaction time led to the formation of some polar side products. Therefore, the reaction mixture 
was worked up at 90% completion, and compound 3, selectively deprotected at position 4, could 
be isolated with 68% yield. Similarly, the NAP group could be removed from primary hydroxyl 
group of 5 in the presence of PMB and benzyl ethers, to yield 6 (Scheme 1). 
 
 
 
Scheme 1. Removal of the (2-naphthyl)methyl group in the presence of the p-methoxybenzyl 
PMB and benzyl groups by catalytic hydrogenation. 
 
Compound 7 was alkylated with (2-naphthyl)methyl bromide in the presence of phase 
transfer catalyst (Bu4NHSO4) affording a mixture of 815 and 9, respectively, whose separation 
has been accomplished by column chromatography. Subsequently, their  p-methyoxybenzylation 
gave the  acetal-containing substrates 10 and 12. Catalytic hydrogenolysis of 10 was let to go to 
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completion, furnishing the mono-deprotected 11.16 The NAP group of 12 could be selectively 
cleaved, as well,  to give 1316 in high yield (Scheme 2).  
 
 
 
Scheme 2. Removal of the (2-naphthyl)methyl group in the presence of the p-methoxybenzyl 
and benzylidene groups. 
 
Starting from the galactopyranoside derivative 14, the synthesis of 17 and 18 was achieved 
by an analogous manner (14→15→17; 14→16→18), but the regioisomers formed in the phase 
transfer alkylation could only be separated after the introduction of the PMB group. The NAP 
group of 17 and 18 could be cleanly removed in the presence of the PMB and benzylidene 
functions to result in 19 and 20 in high yields, respectively. Compounds 17-20 were identified 
after the synthesis and structural elucidation of the acetylated derivative 21 (Scheme 3). 
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Scheme 3. Removal of the (2-naphthyl)methyl group in the presence of the p-methoxybenzyl 
and benzylidene groups. 
 
Orthogonal deprotection of the NAP group was studied at a disaccharide level, too. 2-
(Napthyl)methylation of the single free hydroxyl group of the 3,4-O-Isopropylidene-6-O-
(methoxydimethyl)methyl-β-D-galactopyranosyl-(1→6)-1,2:3,4-di-O-isopropylidene-α-D-
galactopyranose 2217 afforded 23 from which, after mild acidic hydrolysis of the mixed acetal 
group followed by p-methoxybenzylation compound 25 could be obtained. Upon catalytic 
hydrogenation, the NAP group could be cleaved selectively form the secondary hydroxyl group 
to give 26 in high yield (Scheme 4). 
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Scheme 4. Removal of the (2-naphthyl)methyl group in the presence of isopropylidene groups 
by catalytic hydrogenation.  
 
Treatment of the known lactoside 2718 with p-methoxybenzyl chloride as a reagent furnished 
28, as another disaccharide substrate, suitable for studying the selective removal of NAP in the 
presence of PMB and multiple benzyl ethers. Catalytic hydrogenolysis of 28 clearly 
demonstrated the limitation of the method, since the monodeproteced 29 could be isolated in 
rather low yield (Scheme 5). A side product formed in this transformation was also isolated in a 
similar amount; it could be identified, by NMR measurments and its single peak in the mass 
spectrum (m/z: 951.30), as a mixture of mono-debenzylated derivatives of 29 (m/z calcd for 
[M+Na]+: 951.40).  
The higher hydrogenolytic stability of the p-methoxybenzyl ether in comparison to the 
benzyl can be explained by steric effect of the methoxy substituent which inhibits the effective 
binding of the aromatic ring to the catalyst surface.6 This phenomenon was utilized for selective 
hydrogenation of phenolic benzyl ether or ester in the presence of phenolic PMB ether using a 
Pd/C-pyridine combination as a catalyst.19,20  
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Scheme 5. Removal of the (2-naphthyl)methyl group in the presence of benzyl groups by 
catalytic hydrogenation.  
 
 
Conclusions 
 
The (2-naphthyl)methyl (NAP) protecting group could be selectively removed by catalytic 
hydrogenation from primary and secondary hydroxyl  groups in the presence of the p-
methoxybenzyl (PMB), benzylidene and multiple benzyl functions in the case of 
monosaccharides. At a disaccharide level, the p-methoxybenzyl (PMB) group proved to be stable 
toward catalytic hydroganolysis, however, partial cleavage of benzyl ether functions was also 
observed.  
 
 
Experimental Section 
 
General. Optical rotations were measured at room temperature with a Perkin-Elmer 241 
automatic polarimeter. TLC was performed on Kieselgel 60 F254 (Merck) with detection by 
immersing into 5% ethanolic sulfuric acid soln followed by heating. Column chromatography 
was performed on Silica gel 60 (Merck 0.063-0.200 mm). Organic solutions were dried over 
MgSO4, and concentrated in vacuum. The 1H (360, 400 and 500 MHz) and 13C NMR (90.54, 
100.28 and 125.76 MHz) spectra were recorded with Bruker DRX-360, Bruker DRX-400 and 
Bruker DRX-500 spectrometers. Chemical shifts are referenced to Me4Si (0.00 ppm for 1H) or to 
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the residual solvent signals (CDCl3: 77.00 ppm for 13C). MALDI-TOF MS analyses of the 
compounds were carried out in the positive reflectron mode using a BIFLEX III mass 
spectrometer (Bruker, Germany) equipped with delayed-ion extraction. The matrix solution was 
a satd 2,4,6-trihydroxy-acetophenone (THAP) solution in MeCN. A Vario MICRO CUBE 
instrument was used for elemental analyses. 
 
p-Methoxyphenyl 2,3-di-O-benzyl-6-O-(p-methoxybenzyl)-4-O-(2-naphthyl)methyl-β-D-
glucopyranoside (2). Compound 114 (694 mg, 1.14 mmol) was dissolved in DMF (10 ml) then 
60% NaH (69 mg, 1.5 equiv) was added at 0°C and it was stirred for 30 min. p-Methoxybenzyl 
chloride (0.15 mL, 1.3 equiv) was added to the reaction mixture and stirred for further 15 min at 
0°C and 1h at room temperature. The mixture was evaporated, diluted with DCM, washed with 
water (4x), dried, filtered and evaporated. The crude product was purified by column 
chromatography (DCM/acetone 95:5) to yield 2 as white needles (654 mg, 83%). mp = 83-85 oC; 
[α]D25 -8.51 (c 0.67, CHCl3). 1H NMR (360 MHz, CDCl3): δH 7.81- 6.68 (25H, m, arom.), 5.07-
4.44 (9H, m, 4 x CH2, H-1), 3.81-3.67 (5H, m), 3.75 (3H, s, OCH3), 3.71 (3H, s, OCH3), 3.59-
3.58 (1H, m). 13C NMR (90 MHz, CDCl3): δC 159.1-113.6 (arom.), 102.7 (C-1), 84.6, 82.0, 77.6 
(C-2, C-3, C-4, C-5), 75.7, 74.9, 73.1 (4 x CH2), 68.4 (C-6), 55.5, 55.1 (2 x OCH3). Anal. Calcd 
for C46H46O8 (726.85): C, 76.01; H,6.38. Found: C, 76.24; H,6. 36. 
p-Methoxyphenyl 2,3-di-O-benzyl-6-O-(p-methoxybenzyl)-β-D-glucopyranoside (3). To a 
solution of compound 2 (218 mg, 0.03 mol) in a mixture of EtOH and THF (3:1, 20 mL) Pd on 
carbon (30 mg) was added and the mixture was stirred in hydrogen atmosphere until TLC 
showed 90% conversion (6h). It was then filtered through a layer of Celite and concentrated. The 
crude product was purified by column chromatography (DCM/EtOAc 96:4) to yield compound 3 
as white needles (120 mg, 68%). mp = 73-74 oC; [α]D25 -25.65 (c 0.46, CHCl3). 1H NMR (360 
MHz, CDCl3): δH 7.32-6.79 (18H, m, arom.), 5.06-4.74 (5H, m, 2 x CH2, H-1), 4.47, 4.51 (2H, 
2d, Jgem  = 10.5 Hz, CH2), 3.78 (3H, s, OCH3), 3.76 (4H, s, OCH3, skeleton H), 3.70-3.62 (3H, 
m), 3.54-3.49 (2H, m), 2.65 (1H, s, OH). 13C NMR (90 MHz, CDCl3): δC 159.2-113.7 (arom.), 
102.7 (C-1), 83.9, 81.4, 74.2, 71.4 (C-2, C-3, C-4, C-5), 75.3, 74.8, 73.2 (3 x CH2), 69.8 (C-6), 
55.5, 55.2 (2 x OCH3). Anal. Calcd for C35H38O8 (586.26): C, 71.65; H, 6.53. Found: C, 71.50; 
H, 6.55. MALDI-TOF m/z calcd for [M+Na]+: 609.66, Found: 609.41. 
p-Methoxyphenyl 2,3-di-O-benzyl-4-O-(p-methoxybenzyl)-6-O-(2-naphthyl)methyl-β-D-
glucopyranoside (5). Compound 414 (519 g, 0.86 mmol) was treated with p-methoxybenzyl 
chloride (113 µL, 1.2 equiv) as described for the synthesis of compound 2 to yield compound 5 
as a white powder (533 mg, 84%). (Column chromatography: DCM/acetone 95:5). mp = 91-93 
oC; [α]D25 -8.3 (c 0.53, CHCl3). 1H NMR (360 MHz, CDCl3): δH 7.76-6.70 (25H, m, arom.), 
5.04-4.71 (9H, m, 4 x CH2, H-1), 3.83-3.59 (6H, m), 3.72 (3H, s, OCH3), 3.70 (3H, s, OCH3). 
13C NMR (90 MHz, CDCl3): δC 159.2-113.6 (arom.), 102.6 (C-1), 84.6, 82.0, 77.3, 75.0 (C-2, C-
3, C-4, C-5), 75.7, 74.9, 74.6, 73.4 (4 x CH2), 68.7 (C-6), 55.5, 55.1 (2 x OCH3). Anal. Calcd for 
C46H46O8 (726.85): C, 76.01; H, 6.38. Found: C, 75.78; H, 6.41. 
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p-Methoxyphenyl 2,3-di-O-benzyl-4-O-(p-methoxybenzyl)-β-D-glucopyranoside (6). 
Compound 5 (218 mg, 1.05 mmol) was hydrogenolysed as described for the synthesis of 
compound 3 to obtain 6 as white powder (132 mg, 65%). (Column chromatography: 
DCM/EtOAc 96:4). mp = 110-111 oC; [α]D25 -10.71 (c 0.42, CHCl3). 1H NMR (360 MHz, 
CDCl3): δH 7.33-6.81 (18H, m, arom.), 5.03-4.57 (7H, m, 3 x CH2, H-1), 3.88-3.84 (1H, m), 3.77 
(3H, s, OCH3), 3.76 (3H, s, OCH3), 3.72-3.41 (5H, m), 2.15 (1H, s, OH). 13C NMR (90 MHz, 
CDCl3): δC 159.3-113.8 (arom.), 102.4 (C-1), 84.4, 82.0, 77.1, 75.2 (C-2, C-3, C-4, C-5), 75.6, 
75.0, 74.7 (3 x CH2), 61.9 (C-6), 55.6, 55.2 (2 x OCH3). Anal. Calcd for C35H38O8 (586.26): C, 
71.65; H, 6.53. Found: C, 71.82; H, 6.57. MALDI-TOF m/z calcd for [M+Na]+: 609.66, Found: 
609.43. 
Methyl 4,6-O-benzylidene-3-O-(2-naphthyl)methyl-α-D-glucopyranoside (8) and methyl 4,6-
O-benzylidene-2-O-(2-naphthyl)methyl-α-D-glucopyranoside (9). To a stirred solution of 7 
(19.00 g, 67 mmol) in DCM (500 mL) Bu4NHSO4 (2.8 g, 8.2 mmol), 5% aq. NaOH (200 mL) 
and 2-(bromomethyl)naphthalene (20.8 g, 94 mmol, 1.4 eqiuv) were added, then it was stirred 
for 24 hours at reflux temperature. The organic layer was then separated, diluted with DCM, 
washed with water, dried, filtered and concentrated. The crude product was purified by column 
chromatography (n-hexane/EtOAc 6:4) to yield compound 815 and 9.  
(8) White needles, yield: 6.55 g (23%), mp. 199-201°C, [α]D25 +71.73 (c 0.19, CHCl3), (lit. 15 
[α]D25 +69.9); Rf 0.28 (n-hexane/EtOAc 6:4). 1H NMR (500 MHz, CDCl3): δH 7.78-7.35 (12H, 
m, arom.), 5.52 (1H, s, Hac), 5.07-4.92 (2H, 2d, NAP-CH2), 4.73 (1H, d, 3J1,2 = 4.0 Hz, H-1), 
4.27-4.24 (1H, m), 3.85 (1H, t, J = 9.5 Hz), 3.81-3.78 (1H, m), 3.72-3.70 (2H, m), 3.60 (1H, t, J 
= 9.5 Hz), 3.38 (3H, s, OCH3), 2.26 (1H, d, J = 8.2 Hz, OH). 13C NMR (125.7 MHz, CDCl3): δC 
138.37-125.0 (arom.), 101.2 (Cac), 99.9 (C-1), 81.7, 78.7, 72.1, 62.4 (C-2, C-3, C-4, C-5), 74.6 
(NAP-CH2), 68.8 (C-6), 55.2 (OCH3). Anal. Calcd for C25H26O6 (422.47): C, 71.07; H, 6.20. 
Found: C, 71.29; H, 6.17.  
(9) White needles, yield: 14.49 g (51%). [α]D25 +9.85 (c 0.13, CHCl3), mp = 165-166 °C, Rf 0.43 
(n-hexane/EtOAc 6:4). 1H NMR (500 MHz, CDCl3): δH 7.77-7.29 (12H, m, arom.), 5.46 (1H, s, 
Hac), 4.91-4.78 (2H, 2d, NAP-CH2), 4.57 (1H, d, 3J1,2 = 3.5 Hz, H-1), 4.22-4.15 (2H, m), 3.82-
3.75 (1H, m), 3.62 (1H, t, J = 10.5 Hz), 3.48-3.43 (2H, m), 3.32 (3H, s, OCH3), 2.88 (1H, d, J = 
2.2 Hz, OH). 13C NMR (125.7 MHz, CDCl3): δC 137.0-125.7 (arom.), 101.1 (Cac), 98.5 (C-1), 
81.1, 79.3, 70.1, 61.9 (C-2, C-3, C-4, C-5), 73.3 (NAP-CH2), 68.8 (C-6), 55.2 (OCH3). Anal. 
Calcd for C25H26O6 (422.47): C, 71.07; H, 6.20. Found: C, 71.14; H, 6.22. MALDI-TOF m/z 
calcd for [M+Na]+: 445.46, Found: 445.21. 
Methyl 4,6-O-benzylidene-2-O-(p-methoxybenzyl)-3-O-(2-naphthyl)methyl-α-D-
glucopyranoside (10). Compound 8 (1.78 g, 9.59 mmol) was treated with p-methoxybenzyl 
chloride (0.69 mL, 1.2 equiv) as described for the synthesis of compound 2 to yield compound 
10 as white crystals (2.37 g, 88%). (Column chromatography: DCM/EtOAc 97:3) mp = 94-95 
°C, [α]D25 +45.04, (c 0.13, CHCl3). 1H NMR (500 MHz, CDCl3): δH 7.80-6.81 (16H, m, arom.), 
5.54 (1H, s, Hac), 5.06-4.96 (2H, 2d, NAP-CH2), 4.78-4.63 (2H, dd, PMB-CH2), 4.56 (1H, d, 3J1,2 
= 3.5 Hz, H-1), 4.26-4.23 (1H, m), 4.07 (1H, t, J = 9.0 Hz), 3.85-3.79 (1H, m), 3.73 (3H, s, 
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PMB-OCH3), 3.69 (1H, t, J = 10.0 Hz), 3.61 (1H, t, J = 9.0 Hz), 3.56-3.54 (1H, m), 3.37 (3H, s, 
OCH3). 13C NMR (125.7 MHz, CDCl3): δC 159.3-113.8 (arom.), 101.9 (Cac), 99.2 (C-1), 82.1, 
78.9, 78.5, 62.3 (C-2, C-3, C-4, C-5), 75.2, 73.2 (2 x CH2), 69.0 (C-6), 55.2, 55.1 (2 x OCH3). 
Anal. Calcd for C33H34O7 (542.62): C, 73.04; H, 6.32. Found: C, 73.22; H, 6.35. 
Methyl 4,6-O-benzylidene-2-O-(p-methoxybenzyl)-α-D-glucopyranoside (11). To a solution 
of compound 10 (160 mg, 0.23 mmol) in a mixture of EtOH and THF (3:1, 20 mL) Pd on carbon 
(30 mg) was added and the mixture was stirred in hydrogen atmosphere until TLC showed 
complete conversion (6h). It was then filtered through a layer of Celite and evaporated. The 
crude product was purified by column chromatography (DCM/acetone 96:4) to yield compound 
11 as white crystals (84 mg, 71%). mp = 98-100 oC, [α]D25 +78.71 (c 0.16, CHCl3), (lit. 16: mp = 
102 oC, [α]D +38). 1H NMR (360 MHz, CDCl3): δH 7.50-6.87 (9H, m, arom.), 5.51 (1H, s, Hac), 
4.72-4.61 (2H, dd, PMB-CH2), 4.56 (1H, d, 3J1,2 = 3.6 Hz, H-1), 4.27-4.23 (1H, m), 4.12 (1H, t, J 
= 9.3 Hz), 3.83-3.76 (1H, m), 3.79 (3H, s, PMB-OCH3), 3.69 (1H, t, J = 10.1 Hz), 3.51-3.42 (2H, 
m), 3.36 (3H, s, OCH3), 2.72 (1H, bs, OH). 13C NMR (90 MHz, CDCl3): δC 159.5-113.9 (arom.), 
101.8 (Cac), 98.6 (C-1), 81.2, 79.1 70.1, 61.9 (C-2, C-3, C-4, C-5), 72.9 (PMB-CH2), 68.9 (C-6), 
55.3, 55.2 (2 x OCH3). Anal. Calcd for C22H26O7 (402.44): C, 65.66; H, 6.51; O. Found: C, 
65.54; H, 6.49. 
Methyl 4,6-O-benzylidene-3-O-(p-methoxybenzyl)-2-O-(2-naphthyl)methyl-α-D-
glucopyranoside (12). Compound 9 (4.05 g, 9.56 mmol) was treated with p-methoxybenzyl 
chloride as described for the synthesis of compound 2 to give 12 as white crystals (4.56 g, 90%). 
mp = 96-98°C, [α]D25 -49.19 (c 0.62, CHCl3). 1H NMR (500 MHz, CDCl3): δH 7.81-6.80 (16H, 
m, arom.), 5.52 (1H, s, Hac), 4.99-4.78 (4H, m, NAP-CH2, PMB-CH2), 4.59 (1H, d, 3J1,2 = 3.5 
Hz, H-1), 4.25-4.22 (1H, m), 4.06 (1H, t, J = 9.5 Hz), 3.84-3.78 (1H, m), 3.74 (3H, s, PMB-
OCH3), 3.66 (1H, t, J = 10.0 Hz), 3.59-3.55 (2H, m), 3.39 (3H, s, OCH3). 13C NMR (125.7 MHz, 
CDCl3): δC 159.1-113.6 (arom.), 101.1 (Cac), 99.1 (C-1), 82.1, 78.9, 78.5, 62.3 (C-2, C-3, C-4, C-
5), 74.2, 73.7 (2 x CH2), 68.9 (C-6), 55.2, 55.1 (2 x OCH3). Anal. Calcd for C33H34O7 (542.62): 
C, 73.04; H, 6.32. Found: C, 72.89; H, 6.30. 
Methyl 4,6-O-benzylidene-3-O-(p-methoxybenzyl)-α-D-glucopyranoside (13). Compound 12 
(160 mg, 0.23 mmol) was hydrogenolysed as described for the synthesis of compound 11 to 
obtain 13 as white crystals (92 mg, 78%). mp =168-169°C, [α]D25 +78.53 (c 0.11, CHCl3), (lit. 
16: mp = 174-175 oC, [α]D +45). 1H NMR (360 MHz, CDCl3): δH 7.51-6.83 (9H, m, arom.), 5.56 
(1H, s, Hac), 4.89-4.70 (2H, 2d, PMB-CH2), 4.78 (1H, d, 3J1,2 = 3.8 Hz, H-1), 4.31-4.27 (1H, m), 
3.86-3.64 (4H, m), 3.78 (3H, s, PMB-OCH3), 3.62 (1H, t, J = 9.1 Hz), 3.44 (3H, s, OCH3), 2.39 
(1H, d, J = 7.2 Hz, OH). 13C NMR (90 MHz, CDCl3): δC 159.2-113.7 (arom.), 101.2 (Cac), 99.8 
(C-1), 81.9, 78.3, 72.3, 62.5 (C-2, C-3, C-4, C-5), 74.4 (PMB-CH2), 69.0 (C-6), 55.3, 55.2 (2 x 
OCH3). Anal. Calcd for C22H26O7 (402.44): C, 65.66; H, 6.51. Found: C, 65.71; H, 6.55. 
Methyl 4,6-O-benzylidene-2-O-(p-methoxybenzyl)-3-O-(2-naphthyl)methyl-α-D-
galactopyranoside (17)  and methyl 4,6-O-benzylidene-3-O-(p-methoxybenzyl)-2-O-(2-
naphthyl)methyl-α-D-galactopyranoside (18). Compound 14 (840 mg, 3 mmol) was treated 
with 2-(bromomethyl)naphthalene as described for the synthesis of compound 8 and 9 to give the 
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unseparated, purified mixture of compound 15 and 16 (993 mg, 79%). (Column chromatography: 
toluene: acetone 75:25, Rf 0.40 and 0.35.) 
Purified mixture of compound 15 and 16 (736 mg, 1.8 mmol) was treated with p-methoxybenzyl 
chloride as described for the synthesis of compound 2 to yield 17 as white crystals (501 mg, 31% 
over two steps) and 18 as white crystals (535 mg, 33% over two steps). (Column 
chromatography: DCM/Ac 93:7).  
(17) [α]D25 +77.31 (c 0.12, CHCl3), Rf 0.62 (DCM/EtOAc 96:4), mp 89-90°C. 1H NMR (500 
MHz, CDCl3): δH 7.84-6.82 (16H, m, arom.), 5.45 (1H, s, Hac), 4.98-4.86 (2H, 2d, NAP-CH2), 
4.83-4.62 (2H, 2d, PMB-CH2), 4.72 (1H, d, 3J1,2 = 3.5 Hz, H-1), 4.16-4.13 (2H, m), 4.07 (1H, dd, 
J = 3.5 Hz, J = 10.0 Hz), 3.99 (1H, dd, J = 3.5 Hz, J = 10.0 Hz), 3.91 (1H, dd, J = 1.5 Hz, J = 
11.5 Hz), 3.75 (3H, s, PMB-OCH3), 3.48 (1H, s), 3.34 (3H, s, OCH3). 13C NMR (125.7 MHz, 
CDCl3): δC 159.2-113.6 (arom.), 100.9 (Cac), 99.4 (C-1), 75.8, 75.0, 74.8, 62.3 (C-2, C-3, C-4, C-
5), 73.3, 72.2 (2 x CH2), 69.2 (C-6), 55.3, 55.1 (2 x OCH3). Anal. Calcd for C33H34O7 (542.62): 
C, 73.04; H, 6.32. Found: C, 73.14; H, 6.33. MALDI-TOF m/z calcd for [M+Na]+: 565.61, 
Found: 565.49. 
(18) [α]D25 +62.60 (c 0.12, CHCl3), Rf 0.66 (DCM/EtOAc 96:4), mp 101-103°C. 1H NMR (500 
MHz, CDCl3): δH 7.79-6.83 (16H, m, arom.), 5.44 (1H, s, Hac), 5.02-4.67 (4H, 4d, NAP-CH2, 
PMB-CH2), 4.77 (1H, d, 3J1,2 = 3.5 Hz, H-1), 4.15 (1H, dd, 3J5,6a = 1.5 Hz, 2J6a,6b = 12.5 Hz, H-
6a), 4.12 (1H, d, H-4), 4.10 (1H, dd, 3J2,3 = 10.0 Hz, H-2), 3.98 (1H, dd, 3J3,4 = 3.5 Hz, H-3), 3.95 
(1H, dd, 3J5,6b = 1.5 Hz, H-6b), 3.75 (3H, s, PMB-OCH3), 3.52 (1H, s, H-5), 3.37 (3H, s, OCH3). 
13C NMR (125.7 MHz, CDCl3): δC 159.1-113.6 (arom.), 100.9 (Cac), 99.4 (C-1), 75.6, 75.3, 74.6, 
62.4 (C-2, C-3, C-4, C-5), 73.7, 71.6 (2 x CH2), 69.2 (C-6), 55.4, 55.1 (2 x OCH3). Anal. Calcd 
for C33H34O7 (542.62): C, 73.04; H, 6.32. Found: C, 72.90; H, 6.34. MALDI-TOF m/z calcd for 
[M+Na]+: 565.61, Found: 565.48. 
Methyl 4,6-O-benzylidene-2-O-(p-methoxybenzyl)-α-D-galactopyranoside (19). Compound 
17 (160 mg, 0.3 mmol) was hydrogenolysed as described for the synthesis of compound 11 to 
obtain 19 as white crystals (96 mg, 80%). (Column chromatography: DCM/Ac 93:7). [α]D25 + 
60.20 (c 0.50, CHCl3), mp. 92-95 °C. 1H NMR (360 MHz, CDCl3): δH 7.50-6.85 (9H, m, arom.), 
5.54 (1H, s, Hac), 4.74 (1H, d, 3J1,2 = 4.0 Hz, H-1), 4.74-4.57 (2H, 2d, PMB-CH2), 4.26-4.21 (2H, 
m), 4.13-4.08 (1H, m), 4.05 (1H, dd, J = 1.4 Hz, J = 12.5 Hz), 3.82-3.79 (4H, m), 3.65 (1H, s), 
3.36 (3H, s, OCH3), 2.44 (1H, s, OH). 13C NMR (90 MHz, CDCl3): δC 159.3-113.8 (arom.), 
101.1 (Cac), 98.9 (C-1), 76.3, 76.0 68.4, 62.2 (C-2, C-3, C-4, C-5), 72.9 (PMB-CH2), 69.3 (C-6), 
55.5, 55.2 (2 x OCH3). Anal. Calcd for C22H26O7 (402.44): C, 65.66; H, 6.51. Found: C, 65.90; 
H, 6.50. MALDI-TOF m/z calcd for [M+Na]+: 425.43, Found: 425.42. 
Methyl 4,6-O-benzylidene-3-O-(p-methoxybenzyl)-α-D-galactopyranoside (20). Compound 
18 (160 mg, 0.3 mmol) was hydrogenolysed as described for the synthesis of 11 to obtain 20 as 
white crystals (105 mg, 88%). (Column chromatography: DCM/Ac 93:7). [α]D25 +176.87 (c 0.15, 
CHCl3), mp. 175-176°C. 1H NMR (360 MHz, CDCl3): δH 7.53-6.84 (9H, m, arom.), 5.45 (1H, s, 
Hac), 4.94 (1H, d, 3J1,2 = 3.6 Hz, H-1), 4.69-4.62 (2H, 2d, PMB-CH2), 4.25 (1H, dd, 3J5,6a = 1.5 
Hz, 2J6a,6b = 12.4 Hz, H-6a), 4.21-4.17 (2H, m, H-2, H-4), 4.02 (1H, dd, 3J5,6b = 1.5 Hz, H-6b), 
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3.79 (3H, s, PMB-OCH3), 3.77 (1H, dd, 3J2,3 = 10.0 Hz, H-3), 3.60 (1H, s, H-5), 3.44 (3H, s, 
OCH3), 2.30 (1H, s, OH). 13C NMR (90 MHz, CDCl3): δC 159.3-113.8 (arom.), 100.9 (Cac), 99.9 
(C-1), 76.1, 73.5, 67.8, 62.7 (C-2, C-3, C-4, C-5), 71.0 (PMB-CH2), 69.4 (C-6), 55.5, 55.2 (2 x 
OCH3). Anal. Calcd for C22H26O7 (402.44): C, 65.66; H, 6.51. Found: C, 65.49; H, 6.49. 
MALDI-TOF m/z calcd for [M+Na]+: 425.43, Found: 425.43. 
Methyl 2-O-acetyl-4,6-O-benzylidene-3-O-(p-methoxybenzyl)-α-D-galactopyranoside (21). 
To a stirred solution of compound 20 (50 mg, 0.15 mmol) in pyridine (1 mL) Ac2O (0.2 mL) was 
added. When the TLC showed complete conversion, the solvent was evaporated, co-evaporated 
twice with toluene and the residue was purified by column chromatography (DCM/acetone 95:5) 
to yield 21 as a syrup (51 mg, 92%). [α]D25 +15.31 (c 0.11, MeOH). 1H NMR (500 MHz, 
CDCl3): δH 7.54-6.84 (9H, m, arom.), 5.47 (1H, s, Hac), 5.31 (1H, dd, 3J2,3 = 10.5 Hz, H-2), 5.06 
(1H, d, 3J1,2 = 3.4 Hz, H-1), 4.67-4.59 (2H, 2d, PMB-CH2), 4.24 (1H, d, 2J6a,6b = 12.4 Hz, H-6a), 
4.16 (1H, d, 3J3,4 = 3.2 Hz, H-4), 4.01 (1H, d, H-6b), 3.96 (1H, dd, H-3), 3.79 (3H, s, PMB-
OCH3), 3.59 (1H, s, H-5), 3.38 (3H, s, OCH3), 2.10 (3H, s, CH3). 13C NMR (125.7 MHz, 
CDCl3): δC 170.2 (CO), 159.2-113.7 (arom.), 101.0 (Cac), 97.9 (C-1), 74.3, 73.1, 70.1, 62.4 (C-2, 
C-3, C-4, C-5), 71.5 (PMB-CH2), 69.2 (C-6), 55.4, 55.2 (2 x OCH3), 21.0 (CH3). Anal. Calcd for 
C24H28O8 (444.47): C, 64.85; H, 6.35. Found: C, 64.71; H, 6.37.  
3,4-O-Isopropylidene-6-O-(methoxydimethyl)methyl-2-O-(2-naphthyl)methyl-β-D-
galactopyranosyl-(1→6)-1,2:3,4-di-O-isopropylidene-α-D-galactopyranose (23). To a stirred 
solution of compound 2217 (1.3 g, 2.4 mmol) in DMF (10 mL) 60% NaH (150 mg, 2 equiv) was 
added at 0°C. After 30 min 2-(bromomethyl)naphthalene (540 mg, 1.3 equiv) was added to the 
reaction mixture. When TLC (DCM/acetone 75:25 + 1% Et3N) showed complete conversion, it 
was diluted with methanol and evaporated. Usual work-up procedure resulted in compound 23 as 
a syrup (1.55 g, 94%). [α]D25 +0.63 (c 0.53, CHCl3). 1H NMR (360 MHz, CDCl3): δH 7.91-7.42 
(7H, arom.), 5.60 (1H, d, J = 5.1 Hz, H-1), 5.07-5.00 (2H, m, NAP-CH2), 4.61-4.59 (1H, m), 
4.40 (1H, d, J = 8.1 Hz, H-1’), 4.35-4.33 (1H, m), 4.26-4.24 (1H, m), 4.17-4.11 (4H, m), 3.82-
3.65 (4H, m), 3.45-3.40 (1H, m), 3.21 (3H, s, OCH3), 1.55, 1.46, 1.35, 1.34, 1.33, 1.32, 1.29, 
1.20 (24H, 8 x s, 8 x CH3). 13C NMR (90 MHz, CDCl3): δC 136.0-125.5 (arom.), 109.6, 109.2, 
108.5 (3 x Cac), 103.7, 96.3 (C-1, C-1’), 100.0 (MIP-Cac), 78.7, 73.6, 71.9, 71.3, 70.7, 70.4, 67.3 
(skeleton carbons), 73.3 (NAP-CH2), 69.2, 60.1 (C-6, C-6’), 48.5 (MIP-OCH3), 27.6, 26.3, 26.0, 
25.9, 24.9, 24.3, 24.2 (6 x CH3). Anal. Calcd for C36H50O12 (674.77): C, 64.08; H, 7.47. Found: 
C, 64.17; H, 7.44. 
3,4-O-Isopropylidene-2-O-(2-naphthyl)methyl-β-D-galactopyranosyl-(1→6)-1,2:3,4-di-O-
isopropylidene-α-D-galactopyranose (24). Compound 23 (1.038 g, 1.5 mmol) was dissolved in 
DCM (25 mL) and 96% AcOH (1mL) and 1 drop of water were added and it was stirred for 3h at 
reflux temperature. After complete conversion of the starting material it was diluted with DCM 
(60 mL), washed with satd. aq. NaHCO3 and water, dried, filtered and evaporated. Purification 
by column chromatography resulted in compound 24 as white crystals (0.67 g, 73%). [α]D25 
+1.59 (c 0.16, CHCl3). mp:154-156oC. 1H NMR (360 MHz, CDCl3): δH 7.88-7.43 (7H, arom.), 
5.59 (1H, d, J = 5.1 Hz, H-1), 5.04-5.00 (2H, m, NAP-CH2), 4.64-4.61 (1H, dd), 4.42 (1H, d, J = 
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8.1 Hz, H-1’), 4.35-4.29 (2H, m), 4.21-4.07 (4H, m), 3.95-3.90 (1H, m), 3.83-3.76 (3H, m),3.15-
3.12 (1H, m), 3.53 (1H, s, OH), 1.56, 1.49, 1.34, 1.30, 1.21 (18H, 5 x s, 6 x CH3). 13C NMR (90 
MHz, CDCl3): δC 135.8-125.8 (arom.), 110.1, 109.4, 108.6 (3 x Cac), 103.4, 96.4 (C-1, C-1’), 
79.0, 78.6, 73.9, 73.0, 71.1, 70.7, 70.4, 67.1 (skeleton carbons), 73.3 (NAP-CH2), 68.9 (C-6), 
62.4 (C-6’), 27.6, 26.3, 26.0, 25.9, 24.9, 24.3 (8 x CH3). Anal. Calcd for C32H42O11 (602.67): C, 
63.77; H, 7.02. Found: C, 63.97; H, 7.03. 
3,4-O-Isopropylidene-6-O-(p-methoxybenzyl)-2-O-(2-naphthyl)methyl-β-D-galactopyranosyl- 
(1→6)-1,2:3,4-di-O-isopropylidene-α-D-galactopyranose (25). Compound 24 (380 mg, 0.63 
mmol) was treated with p-methoxybenzyl chloride as described for the synthesis of compound 2 
to yield 25 as a syrup (382 mg, 84%). (Column chromatography n-hexane/acetone 75:25). [α]D25 
+0.46 (c 0.19, CHCl3). 1H NMR (360 MHz, CDCl3): δH 7.88-6.84 (11H, arom.), 5.59 (1H, d, J = 
5.1 Hz, H-1), 5.06-5.00 (2H, m, NAP-CH2), 4.59-4.47 (3H, m), 4.40 (1H, d, J = 8.0 Hz, H-1’), 
4.14-4.10 (6H, m), 3.89-3.85 (1H, m), 3.77 (3H, s, OCH3), 3.75-3.70 (3H, m), 3.40-3.38 (1H, m), 
1.55, 1.44, 1.32, 1.30, 1.29, 1.17 (18H, 6 x s, 6 x CH3). 13C NMR (90 MHz, CDCl3): δC 159.1-
113.6 (arom.), 109.7, 109.3, 108.7 (3 x Cac), 103.7, 96.3 (C-1, C-1’), 78.6, 78.5, 73.6, 71.9, 71.3, 
70.6, 70.3, 67.4 (skeleton carbons), 73.2, 73.1 (2 x CH2), 68.5, 67.9 (C-6, C-6’), 55.1 (OCH3), 
27.6, 26.3, 26.0, 25.9, 24.9, 24.3 (6 x CH3). Anal. Calcd for C40H50O12 (722.82): C, 66.47; H, 
6.97. Found: C, 66.24; H, 6.99. 
3,4-O-Isopropylidene-6-O-(p-methoxybenzyl)-β-D-galactopyranosyl-(1→6)-1,2:3,4-di-O-
isopropylidene-α-D-galactopyranose (26). Compound 25 (700 mg, 1.05 mmol) was 
hydrogenolysed as described for the synthesis of compound 11 to obtain 26 as a syrup (441 mg, 
71%). (Column chromatography: DCM/acetone 9:1). [α]D25 +0.51 (c 0.16, CHCl3). 1H NMR 
(500 MHz, CDCl3): δH 7.27-6.86 (4H, arom.), 5.53 (1H, d, J = 5.5 Hz, H-1), 4.59-4.47 (3H, m), 
4.31-4.20 (3H, m), 4.14-4.12 (1H, m), 4.07-4.02 (3H, m), 4.00-3.91 (1H, m), 3.79 (3H, s, OCH3), 
3.78-3.72 (3H, m), 3.58-3.55 (1H, m), 3.20 (1H, s, OH), 1.52, 1.50, 1.43, 1.33, 1.31, 1.20 (18H, 
6 x s, 6 x CH3). 13C NMR (125.7 MHz, CDCl3): δC 159.1, 129.9, 129.2, 113.4 (arom.), 109.8, 
109.3, 108.6 (3 x Cac), 103.3, 96.1 (C-1, C-1’), 78.7, 73.5, 73.2, 72.5, 71.1, 70.6, 70.3, 67.8 
(skeleton carbons), 73.1 (PMB-CH2), 69.1, 68.9 (C-6, C-6’), 55.1 (OCH3), 28.0, 26.2, 25.9, 25.8, 
24.8 (6 x CH3). Anal. Calcd for C29H42O12 (582.64): C, 59.78; H, 7.27. Found: C, 59.88; H, 7.30. 
p-Methoxyphenyl 2,6-di-O-benzyl-4-O-(p-methoxybenzyl)-3-O-(2-naphthyl)methyl-ß-D-
galactopyranosyl-2,3,6-tri-O-benzyl-ß-D-glucopyranoside (28). Compound 2718 (234 mg, 0.23 
mmol) was treated with p-methoxybenzyl chloride as described for the synthesis of compound 2 
to yield 28 as a syrup (234 mg, 92%). (Column chromatography: n-hexane/EtOAc 8:2). [α]D25 
+1.54 (c 0.13, CHCl3). 1H NMR (360 MHz, CDCl3): δH 7.77-6.76 (40H, arom.), 5.07-4.75 (10H, 
m), 4.56-4.23 (6H, m), 3.99-3.94 (2H, m), 3.80-3.37 (16H, m). 13C NMR (90 MHz, CDCl3): δC 
158.9-113.5 (arom.), 102.8, 102.7 (C-1, C-1’), 82.9, 82.4, 81.5, 79.9, 76.7, 75.3, 72.9 (skeleton 
carbons), 75.4, 75.1, 74.2, 73.7, 72.4 (7 x CH2), 68.3, 68.1 (C-6, C-6’), 55.5, 55.2 (2 x OCH3). 
Anal. Calcd for C73H74O13 (1159.36): C, 75.63; H, 6.43. Found: C, 75.76; H, 6.41. MALDI-TOF 
m/z calcd for [M+Na]+: 1181.50, Found: 1181.77. 
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p-Methoxyphenyl 2,6-di-O-benzyl-4-O-(p-methoxybenzyl)-ß-D-galactopyranosyl-2,3,6-tri-
O-benzyl-ß-D-glucopyranoside (29). Compound 28 (110 mg, 0.01 mmol) was hydrogenolysed 
as described for the synthesis of compound 3 to obtain 29 as a syrup (16 mg, 17%). (Column 
chromatography: DCM/acetone 97:3, Rf 045 ). 1H NMR (360 MHz, CDCl3): δH 7.31-6.77 (33H, 
arom.), 5.06-4.27 (14H, m), 4.01-3.39 (19H, m). 13C NMR (90 MHz, CDCl3): δC 159.2-113.7 
(arom.), 102.7 (C-1, C-1’), 82.9, 81.5, 80.7, 76.6, 75.5, 75.3, 74.0, 73.2 (skeleton carbons), 75.4, 
75.1, 75.0, 74.7, 73.3, 73.1 (6 x CH2), 68.3, 67.9 (C-6, C-6’), 55.6, 55.2 (2 x OCH3). Anal. Calcd 
for C62H66O13 (1019.18): C, 73.06; H, 6.53. Found: C, 73.16; H, 6.50. MALDI-TOF m/z calcd 
for [M+Na]+: 1041.44, Found: 1041.39.  
Another chromatographically uniform product with lower mobility (DCM/acetone 97:3, Rf 0.21) 
was also isolated (13 mg). MALDI-TOF m/z calcd. for [M+Na]+ of mono-debenzylated 
derivative of 29: 951.40, found: 951.30. The NMR spectra showed a mixture of isomers 
possessing the PMB group.  
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